Baxter Reports Solid First Quarter Financial Results and Raises Full-Ye... (ted share on an after-tax basis) ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

Date:4/17/2008

ted share, on an after-tax basis)

related to COLLEAGUE infusion pumps and $19 million ($11 million, or

$0.02 per diluted share, on an after-tax basis) related to the

company's recall of heparin sodium injection vial products in the

United States.

(2) Other Income, Net in 2008 included income of $16 million

($10 million, or $0.02 per diluted share, on an after-tax basis) due

to the finalization of the net assets transferred in the divestiture

of the Transfusion Therapies (TT) business. Other Income, Net in

2007 included income of $23 million, reflecting a gain on the sale

of the TT business of $58 million less related charges of

$35 million. The after-tax impact of the gain and related charges

in 2007 was $6 million of income, or $0.01 per diluted share.

(3) Refer to page 7 for a description of the adjustment and a

reconciliation to GAAP (generally accepted accounting principles)

measures.

Non-GAAP Financial Measures: The non-GAAP financial measures contained in

this press release (pre-tax income, net income and per-share earnings,

excluding certain items) adjust for factors that are unusual or

nonrecurring. Unusual or nonrecurring items can be highly variable,

difficult to predict, and of a size that may substantially impact the

company's reported operations for a period. Management believes that

non-GAAP financial measures can facilitate a fuller analysis of the

company's results of operations, particularly in evaluating performance

period over period. Management uses these non-GAAP financial measures

internally in financial planning, to monitor business unit performance,

and in evaluating management performance. Refer to the company's filing

on Form 8-K of today's date for additional information.

'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing

Post Your Comments:

(Date:12/17/2009)... the Daveys, the GLOBALS, ,and PM360 Pharma Choice Awards Programs. ... ... -- Chicago-based full-service healthcare communications agency Goble & Associates, Inc. ... honoring exceptional creative and interactive work. , , ,THE RX ... Awards of Excellence for the following creative work: Hospira LifeShield ...

(Date:12/16/2009)... historians, journalists and politicians, and has been recounted everywhere ... Congress: British forces used chemical weapons on Iraqis just ... has never been fully squared with the historical record, ... According to Douglas,s research, forthcoming in the December issue ... such incident ever occurred. , Allegations of chemical ...

(Date:12/16/2009)... found that certain cardiac pacemakers may inadequately stimulate ... imaging (MRI) scan due to the magnetic pulses ... This inadequate stimulation is potentially dangerous for ... research published in BioMed Central,s open access journal ... an imaging technique that uses a magnetic field ...

(Date:12/16/2009)... Md., Dec. 16 Martek Biosciences Corporation (Nasdaq: ... the fourth quarter and fiscal year ended October 31, ... down 3% from $90.4 million in the fourth quarter ... $0.33 per diluted share, for the fourth quarter of ... or $0.31 per diluted share, in last year,s fourth ...

[0] Goble & Associates Creative Work Awarded at Advertising Industry Competitions [0] Despite claims, UK did not gas Iraqis in the 1920s, new research finds [0] FDA researchers identify new MRI safety risk for patients with pacemakers [0] Martek Announces Fourth Quarter and FY 2009 Financial Results

... InterMune, Inc.,(Nasdaq: ITMN ) today announced results from ... The company also provided 2008,financial guidance and milestones for its ... InterMune reported a net loss for the fourth quarter ... a net loss of $21.5 million, or,$0.64 per share, in ...

... Feb. 7 LifeCell Corporation,(Nasdaq: LIFC ), today ... due to the final settlement of a claim that ... is expected to reduce,diluted net income per share by ... in 2008, since the Company,s 2007,financial statements were not ...

... ATLANTA, Feb. 7 CryoLife, Inc., (NYSE: ... tissue processing company, today announced,that it has ... Drug Administration,(FDA) for its CryoValve(R) SG pulmonary ... SynerGraft technology. CryoLife,s proprietary,SynerGraft technology is designed ...

InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves

(Date:12/16/2009)... Tom Bowman, an expert in communicating scientific issues to ... developed a series of graphics that translate key figures ... report for public audiences. These new graphics provide non-experts ... make informed decisions about climate change risks and opportunities. ... to clearly and accurately communicate findings in the IPCC ...

(Date:12/16/2009)... GestureTek Inc. today announced the launch of ... portable, plug and play interactive projection display ... promotions. GestureTek is the inventor and holder ... recognition technology for interactive display, presentation and ... CUBE has TUV, CE, CSA and EMI ...

(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...

[0] Bowman creates graphic translation of climate change data [0] GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits [0] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division

... Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) ... to silence a mutated gene that causes inherited cases ... onset and the progression rate of the fatal motor ... April issue of Nature Medicine, and in the journal's ...

... (MUHC) in Montreal is pleased to announce the first successful ... by Professor Seang Lin Tan, Chair of the Department of ... McGill Reproductive Centre at the MUHC in Montreal confirmed the ... 29. "We are the first in-vitro fertilization (IVF) Centre in ...

... harmful chemicals and drugs during critical developmental periods early ... respond to the female hormone estrogen. This genetic reprogramming ... a disease actually develop the disease. , The new ... to uterine tumors also receive an early-life exposure to ...

Other Biology News:Silence the gene, save the cell: RNA interference as promising therapy for ALS 2 Silence the gene, save the cell: RNA interference as promising therapy for ALS 3 First frozen egg baby born in Canada 2 First frozen egg baby born in Canada 3 Harmful chemicals may reprogram gene response to estrogen 2 Harmful chemicals may reprogram gene response to estrogen 3

Silence the gene, save the cell: RNA interference as promising therapy for ALS First frozen egg baby born in Canada Harmful chemicals may reprogram gene response to estrogen

Request Info...

1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...

... bioinformatics software that has changed the way ... design of BioNumerics allows for integration and ... data employed for the characterization of organisms ... protein gels, HPLC, VNTR, MLST, SNP, fatty ...

Request Info...

Biology Products:

Feline IL-10 ELISpot Development Kit from R&D Systems Custom Protein Cloning & Expression Services (Insect) from Proteome Resources BioNumerics from Applied Maths Basement Membrane Extract Reduced Growth Factor from R&D Systems

Baxter Reports Solid First Quarter Financial Results and Raises Full-Ye...(ted share on an after-tax basis) ...)